Latest Biologic Stories
MONROVIA, Calif., Dec. 18, 2014 /PRNewswire/ -- Xencor, Inc.
Global Regenerative Medicine Market 2015-2019 industry research report says the latest trend seen in the market is increasing in Mergers and acquisitions (M&A). Dallas,
SAN DIEGO, Dec. 17, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.
CSL Behring Continues Improving Patient Well-Being; Key Milestone Achieved in PROLONG-9FP, Company's Recombinant Factor IX Fusion Protein Development Program KING OF PRUSSIA,
Experimental monoclonal antibody to be used in clinical trials with patients in West Africa infected with the Ebola virus.
CAMBRIDGE, England, December 16, 2014 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces a further equity investment from Astellas Venture Management
ReportsandReports.com adds latest reports on Adalimumab Industry for Global and China Markets to its store. DALLAS, Dec.
First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif. and LONDON, Dec.
The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.
NEW YORK, Dec.
- To fire mitraille at.